Abstract
Quetiapine is a recently introduced atypical antipsychotic. Although adverse effects are mainly mild, more serious infrequent adverse effects including leucopenia are mentioned. We describe three case-reports concerning haematological adverse effects of quetiapine. Quetiapine was associated with leucopenia in two patients and clinically apparent agranulocytosis in one patient. Although a definite association has not been proven, clinicians should be aware of the possibility of agranulocytosis while using quetiapine. Further post-marketing surveys are required
Original language | English |
---|---|
Pages (from-to) | 311-3; discussion 313-4 |
Journal | Acta psychiatrica Scandinavica |
Volume | 104 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2001 |